IPX066 145 (Rytary carbidopa 36.25 mg / levodopa 145 mg)
Generic Name: carbidopa/levodopa
Pill with imprint IPX066 145 is Blue, Capsule-shape and has been identified as Rytary carbidopa 36.25 mg / levodopa 145 mg. It is supplied by Amneal Pharmaceuticals LLC.
Rytary is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Rytary carbidopa 36.25 mg / levodopa 145 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IPX066 145
Rytary
- Generic Name
- carbidopa/levodopa
- Imprint
- IPX066 145
- Strength
- carbidopa 36.25 mg / levodopa 145 mg
- Color
- Blue
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 648960662
More about Rytary (carbidopa / levodopa)
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 23 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Approval History
Consumer resources
- Other brands
- Sinemet, Sinemet CR, Duopa, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.